Case Overview

| | |

|---|---|

| Cases Covered | 3 |

| Earliest Deadline | See individual cases |

| Verticals | Consumer Tech, AI/Privacy, Mass Tort |

| Last Updated | March 2026 |

Three Consumer Legal Developments to Watch This Week: Google Play, Meta AI Glasses, and J&J Baby Powder

Several significant consumer legal developments emerged this week, spanning a settled class action over subscription billing practices, a newly filed lawsuit targeting AI-powered smart glasses, and a jury verdict in one of the country's most closely watched mass tort cases. Here's a breakdown of what happened and what it may mean for affected consumers.

1. Google Play Subscription Settlement

Deadline: To be determined (settlement pending court approval)

Estimated Payout: Varies; funded by a $5 million settlement pool

Who Qualifies: California residents who were charged for Google Play subscriptions subject to automatic renewal practices

Google has agreed to a $5 million class action settlement to resolve claims that it violated California's automatic renewal law in connection with Google Play subscriptions. The lawsuit alleged that Google failed to properly disclose automatic renewal terms to subscribers before charging them, as required under California statute.

According to the complaint, affected consumers were enrolled in recurring billing cycles without receiving adequate notice of the renewal terms or a clear mechanism to cancel before charges were applied. Google has not admitted wrongdoing as part of the settlement.

California residents who purchased Google Play subscriptions during the relevant period may be eligible to submit a claim. Proof of purchase requirements and the official claim filing window have not yet been confirmed pending court approval.

How to claim: Monitor the settlement details page for updates on the claim filing period and official settlement website once the court issues its preliminary approval order.

2. Meta AI Glasses: Class Action Alleges Undisclosed Recordings Trained AI Models

Deadline: N/A — Lawsuit in early stages; no settlement announced

Estimated Payout: Not yet determined

Who Qualifies: Individuals who used Meta's Ray-Ban smart glasses

Meta Platforms is facing a newly filed class action lawsuit alleging that its AI-enabled smart glasses captured and transmitted video recordings to third-party contractors without users' knowledge — and that those recordings were used to train artificial intelligence systems.

According to the complaint, Meta failed to disclose to purchasers and bystanders that video footage captured by the glasses could be reviewed by human contractors as part of its AI development process. The lawsuit alleges this practice violated users' reasonable expectations of privacy and that the product's disclosures were materially incomplete.

The plaintiffs claim that had they been aware their recordings were being used in this manner, they would not have purchased the product or would have paid significantly less for it. The case raises broader questions about transparency obligations for consumer AI hardware — a rapidly expanding product category with limited established precedent.

Meta has not yet publicly responded to the allegations. The lawsuit is in its early stages, and no settlement or trial date has been set.

How to follow: Keep an eye on court filings for this case as it develops. Consumers who own Meta Ray-Ban smart glasses and have concerns about their data may wish to consult the product's current privacy disclosures.

3. J&J Baby Powder Verdict: Pennsylvania Jury Awards $250,000 in Ovarian Cancer Case

Deadline: N/A — Individual jury verdict; part of ongoing mass tort litigation

Estimated Payout: $250,000 awarded in this case; broader litigation ongoing

Who Qualifies: Individuals who used Johnson's Baby Powder and developed ovarian cancer may have separate legal options — consult an attorney

A Philadelphia jury has returned a verdict against Johnson & Johnson, awarding $250,000 to the family of a woman who died from ovarian cancer after decades of using the company's talc-based baby powder. The verdict adds to a growing body of jury decisions finding the company liable in connection with its talcum powder products.

While the award is modest relative to some earlier verdicts in talc litigation — some of which reached into the billions — legal observers note that the decision signals continued jury willingness to hold Johnson & Johnson accountable despite the company's aggressive defense posture. J&J has maintained that its baby powder is safe and that scientific evidence does not support a causal link between talc use and ovarian cancer.

The case is part of Philadelphia's broader mass tort program handling thousands of similar claims. Johnson & Johnson has faced significant legal and financial pressure related to its talc products, including a controversial attempt to use bankruptcy proceedings to resolve the litigation — a strategy that courts have scrutinized closely.

Research has suggested a possible association between long-term genital talc use and ovarian cancer, though causation remains disputed in scientific and legal contexts. The company discontinued its talc-based baby powder in the United States in 2020, citing what it called a "misinformation-driven" decline in demand.

How to follow: Individuals who used talc-based Johnson's Baby Powder and have been diagnosed with ovarian cancer may wish to speak with a qualified attorney about their potential legal options. This is an active and evolving area of litigation.

Key Takeaways

• The Google Play settlement is funded at $5 million — eligible California consumers should watch for the official claim filing window once the court grants preliminary approval, as deadlines can arrive quickly after that stage.
• The Meta AI glasses lawsuit is in early stages — no compensation is available yet, but the case may establish important precedent around AI hardware transparency obligations for consumers.
• The J&J talc verdict, while relatively modest in dollar amount, reflects sustained jury skepticism of the company's defense in thousands of pending cases — the litigation is far from over.
• Data breach and subscription billing cases often don't require extensive documentation — but product defect and personal injury cases typically have stricter eligibility criteria and proof requirements.
• Check your purchase history — consumers who subscribed to Google Play services, purchased Meta smart glasses, or used talc-based personal care products for extended periods may want to assess whether they fall within the relevant class definitions.

Have you filed a claim in any of these cases, or do you have a question about your eligibility? Share your experience in the comments below.

InjuryClaims.com reports on litigation developments for informational purposes only. Nothing in this article constitutes legal advice. Eligibility for any settlement or lawsuit is determined by attorneys and courts, not by this publication.